UroGen Pharma
URGN
URGN
74 hedge funds and large institutions have $497M invested in UroGen Pharma in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
17% more funds holding
Funds holding: 63 → 74 (+11)
6.2% more ownership
Funds ownership: 59.54% → 65.73% (+6.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
74
Holding in Top 10
3
Calls
$1.38M
Puts
$447K
Top Buyers
| 1 | +$19.4M | |
| 2 | +$17.7M | |
| 3 | +$16.8M | |
| 4 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$13.1M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$11.4M |
Top Sellers
| 1 | -$7.56M | |
| 2 | -$1.67M | |
| 3 | -$700K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$653K |
| 5 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
-$636K |